☆ 4.4 Article

Infliximab Originator, Infliximab Biosimilar, and Adalimumab Are More Effective in Crohnʼs Disease Than Ulcerative Colitis

Clinical and Translational Gastroenterology (2020)

Journal

Clinical and Translational Gastroenterology

Volume 11, Issue 5, Pages e00177

Publisher

Ovid Technologies (Wolters Kluwer Health)

DOI: 10.14309/ctg.0000000000000177

Keywords

-

Categories

Gastroenterology & Hepatology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.